% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{McCrary:309879,
author = {J. M. McCrary and E. Van Valckenborgh and D. Horgan and E.
Aleksandrova and R. Bargou and R. L. Behulova and I. Belina
and A. L. E. Bøhme and J. Brunet and F. Burada and A.
Chirita-Emandi and A. Ciuca and C. Colas and A.
Constantinidou and R.-O. Curca and V. Cursaru and M. Dalmas
and Z. Daneberga and E. de Azambuja and A. De Pauw and R. De
Putter and T. Delikurt-Tuncalp and D. Donnelly and H.
Ehrencrona and L. Foretova and F. Galli and M. Genuardi and
R. Giles and C. Grima and R. Janavičius and H.
Kääriäinen and B. Klink and M. Krajc and J.
Kufel-Grabowska and B. Lace and L. Leitsalu and C. Le
Tourneau and M. Lodahl and F. Mari and E. Matos and L.
Mazzarella and T. H. Milagre and M. Mistrik and B. Moss and
A. Nolan and R. O'Shea and M. Paneque and A. Patócs and R.
Pestoff and H. A. Poirel and M. Risch and M. Rodrigues and
K. M. Roetzer and A. Ros and E. Schröck$^*$ and G.
Schwaninger and L. Slámová and K. Stamatopoulos and S.
Strang-Karlsson and K. Szczałuba and V. Szymczak and P.
Theis and J. Turner and O. Valcina and C. Vella and W. A. G.
van Zelst-Stams and K. A. W. Wadt and J. Zschocke and J.
Ronez and T. Ripperger and M. Van Den Bulcke and A. K.
Bergmann},
title = {{P}riority {E}uropean strategies for sustainable access to
high-quality genetic counselling in cancer: {A} {D}elphi
study.},
journal = {European journal of human genetics},
volume = {nn},
issn = {1018-4813},
address = {Basingstoke},
publisher = {Stockton Press},
reportid = {DKFZ-2026-00364},
pages = {nn},
year = {2026},
note = {#DKTKZFB26# / #NCTZFB26# / epub},
abstract = {Europe's Beating Cancer Plan is a substantial European
Union (EU) investment into cancer prevention and treatment.
Integration of genetic services towards personalised cancer
prevention and care is a flagship of this plan. Genetic
counselling is critical to this integration, facilitating
informed patient decision making and improved clinical
management. However, growing demands for genetic testing and
concurrently increasing workforce shortages necessitate new
strategies to equitably ensure sustainable access to
counselling across the EU. This project aimed to inform
future European activities by identifying priority European
strategies for addressing common European genetic literacy,
workforce, and reimbursement barriers to genetic counselling
in cancer noted in prior work. A Delphi survey was
conducted, with genetics, oncology, and patient stakeholders
invited from all EU Member States. The response rate was
$62\%$ (124 total invitations). Over three phases, 77
participants - 28 geneticists; 14 oncologists; 18 genetic
counsellors; 16 patient representatives; 1 otherwise
qualified expert - rated 19 strategies according to their
Importance, Urgency, and Feasibility and selected their top
three priority strategies. Five strategies met pre-defined
consensus thresholds and received a clear plurality of
priority ratings: (1) EU-wide genetic counsellor
recognition; (2) Including genetics expertise in oncology
guideline creation; (3) Shared EU genetic counsellor
registration/education with legal weight; (4) Mandatory
counselling reimbursement when clinical guidelines are met;
(5) Mandatory inclusion of genetics in oncology
fellowship/continuing education. Results provide a roadmap
of European actions which promise to sustainably improve
access to genetic counselling in cancer care. Upcoming and
ongoing EU projects promise to advance their
implementation.},
cin = {DD01 / DD04},
ddc = {610},
cid = {I:(DE-He78)DD01-20160331 / I:(DE-He78)DD04-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41688774},
doi = {10.1038/s41431-026-02015-y},
url = {https://inrepo02.dkfz.de/record/309879},
}